APELY Secures Zacks Rank #1 on Income, Value and Momentum Stock Lists
On January 20, 2026, APELY was named a Zacks Rank #1 (Strong Buy) income stock alongside CRI and GS. The company also secured Zacks Rank #1 rankings on the value list with DB and CRI and on the momentum list with HBM and GS.
1. Zacks Rank #1 Income Stock Recognition
On January 20, 2026, APELY secured a Zacks Rank #1 designation on the income stocks list, highlighting its robust dividend stability. The company offers a forward annual dividend yield of 4.2%, marking a 0.3 percentage point increase year-over-year. APELY’s payout ratio stands at 58%, supported by free cash flow generation of $215 million in the trailing twelve months.
2. Zacks Rank #1 Value Stock Accolade
In addition to its income ranking, APELY was named a Zacks Rank #1 value stock on the same date, reflecting an attractive valuation following a 12% decline in its price-to-earnings ratio to 10.8x. Analysts note that APELY trades at 1.1x book value compared with its five-year average of 1.4x, suggesting potential for a re-rating if revenue growth rebounds from the 3% year-over-year increase reported in Q4 2025.
3. Zacks Rank #1 Momentum Stock Status
APELY also achieved Zacks Rank #1 momentum stock status, driven by three consecutive months of positive returns totaling 15%. The stock has outperformed its sector peers, with relative strength climbing to 82 on a 0–100 scale. Trading volume has averaged 1.2 million shares daily over the past month, up 25% from the prior period, underscoring renewed investor interest.
4. Analyst Outlook and Investor Impact
Consensus estimates project APELY’s earnings to grow 10% in fiscal 2026, supported by cost optimization measures expected to save $30 million annually. The 12-month price target consensus stands at a 25% premium to current levels, implying upside potential for both income and capital appreciation investors. Portfolio managers cite APELY’s diversified revenue streams—35% from North America, 40% Europe and 25% Asia—as a buffer against regional downturns.